Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

SpotSee Acquires Sensor International’s Unique Patented Indicator Technologies

Acquisition to Support the Company’s Key Global Life Science Solutions

SpotSee, a global leader in environmental condition monitoring solutions, has acquired unique temperature indicator technologies and intellectual property from Sensor International. Sensor International has developed and patented unique and intelligent indicator technologies that can be integrated into various products, packaging, medical devices, and diagnostics. These technologies are particularly useful in life science, food safety and high-pressure pasteurization markets.

AiThority Interview Insights: AiThority Interview with Ramsey Masri, Chief Executive Officer at Ceres Imaging

“We look forward to working with the Sensor Indicator team to develop and commercialize these unique technologies into real world applications.”

“SpotSee sees a tremendous opportunity with the Sensor Indicator technologies because of its low-cost, time-temperature detection capabilities that can mimic spoilage experienced in vaccine vial monitoring, pharmaceuticals and food,” said Tony Fonk, President and CEO of SpotSee. “We look forward to working with the Sensor Indicator team to develop and commercialize these unique technologies into real world applications.”

This is the second acquisition announced by SpotSee in the past two weeks, reaffirming its commitment to develop the best patient-focused Life Science solutions, as well as products for food distribution monitoring.

Read More about AiThority InterviewAiThority Interview with Jim Kaskade, Chief Executive Officer at Conversica

The World Health Organization (WHO) mandates that manufacturers utilize vaccine vial monitors, enabling millions of vaccines to reach rural patients throughout the globe without spoilage. Through the acquisition of Sensor International, SpotSee will continue its development of key solutions to support the distribution and monitoring of vaccine and temperature sensitive medication.

According to the IQVIA Institute for Human Data Science, 30% of cold chain products are scrapped because of cold chain issues.

“SpotSee is a purpose driven company, and we are motivated to create unique technologies that help solve a global health problem,” said Fonk. “We are proud of our role to help reduce waste in the pharmaceutical supply chain. Imagine if we had 30% more medicine to reach those in need.”

 Latest AiThority Interview Insights : AiThority Interview with Itamar Kandel, Chief Executive Officer at

 [To share your insights with us, please write to] 

Comments are closed.